WASHINGTON (Reuters) – Asian stocks were set to climb on Wednesday after another late Wall Street surge in action to positive trial results for a COVID-19 treatment and data showing U.S. customers spent huge in Might.
SUBMIT IMAGE: A male wearing a protective face mask, following the coronavirus disease (COVID-19) outbreak, is silhouetted in front of a stock quote board outside a brokerage in Tokyo, Japan, June 15,2020 REUTERS/Kim Kyung-Hoon
The prospects of fresh support from the Federal Reserve and Bank of Japan also supported global equity markets.
” It was a trifecta of positives today,” said Jeffrey Carbone, a partner at North Carolina-based Cornerstone Wealth, referring to the U.S. information, drug trials and reserve bank promises.
The upbeat belief weighed of U.S. Treasuries and supported need for lower-rated southern European debt. Not everybody was in the mood for danger, nevertheless, with safe-have gold pressed greater on news of a fresh coronavirus outbreak in China.[GOL/]
” We got potentially more favorable news in the